XenoPort has received a US patent for, prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use. The patent is directed to composition and formulations of the XP23829 compound and another patent ...
Tags: XenoPort, US patent, covering composition
GlaxoSmithKline (GSK) and XenoPort have gained FDA approval for Horizant (gabapentin enacarbil) extended-release tablets for postherpetic neuralgia (PHN). A single 12-week principal efficacy trial and two supportive studies that met their ...
Astellas Pharma and XenoPort have announced the introduction of Regnite (gabapentin enacarbil) extended-release tablets in Japan for the treatment of moderate-to-severe primary restless legs syndrome (RLS). Regnite, which was discovered ...
Tags: Rls Drug, Restless legs syndrome, Regnite extended-release tablets